Lonza Group AG is a contract development and manufacturing organization serving pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand and internationally. Its Integrated Biologics, Advanced Synthesis and Specialized Modalities segments provide biologics manufacturing, ADCs, small molecules and highly potent APIs, and cell & gene, microbial, bioscience and mRNA technologies.